Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 11,202,000 | 9,702,000 | 8,385,385 | 7,949,420 | 7,011,383 |
| Cost of Goods | 2,859,000 | 2,471,000 | 2,124,410 | 1,869,876 | 1,595,558 |
| Gross Profit | 8,343,000 | 7,231,000 | 6,260,975 | 6,079,544 | 5,415,825 |
| Operating Expenses | 3,819,000 | 3,221,000 | 2,471,544 | 2,118,198 | 1,887,162 |
| Operating Income | 4,524,000 | 4,010,000 | 3,789,841 | 3,962,222 | 3,529,221 |
| Interest Expense | 307,000 | 361,000 | 205,418 | 108,961 | 69,662 |
| Other Income | -9,000 | -37,000 | 66,581 | 60,287 | 42,397 |
| Pre-tax Income | 4,208,000 | 3,612,000 | 3,651,004 | 3,913,548 | 3,501,956 |
| Income Tax | 1,151,000 | 1,038,000 | 861,945 | 1,023,799 | 876,364 |
| Net Income Continuous | 3,057,000 | 2,574,000 | 2,789,059 | 2,889,749 | 2,625,592 |
| Minority Interests | -18,000 | -18,000 | -14,578 | -11,508 | -10,163 |
| Net Income | $3,075,000 | $2,592,000 | $2,803,637 | $2,901,257 | $2,635,755 |
| EPS Basic Total Ops | 2.01 | 1.71 | 1.81 | 1.69 | 1.46 |
| EPS Basic Continuous Ops | 2.00 | 1.70 | 1.80 | 1.69 | 1.45 |
| EPS Diluted Total Ops | 1.81 | 1.64 | 1.77 | 1.66 | 1.41 |
| EPS Diluted Continuous Ops | 1.80 | 1.63 | 1.77 | 1.65 | 1.41 |
| EBITDA(a) | $4,869,000 | $4,288,000 | $4,092,073 | $4,227,699 | $3,742,165 |